文献速递生殖医学

早发性卵巢功能不全女性的激素治疗:系统综述与荟萃分析

Hormone therapy in women with premature ovarian insufficiency: a systematic review and meta-analysis.
PubMed 文献 · Reprod Biomed Online · 2022-02-15

该系统综述与荟萃分析纳入28项研究的30篇报告,共4004例不同病因的早发性卵巢功能不全(POI)女性,其中3785例接受激素治疗,219例接受钙剂、维生素D、安慰剂或无治疗。激素治疗在维持骨密度方面优于非治疗、安慰剂、骨化三醇或钙剂,与潮热患病率降低最高达80%相关,并与生活质量评分稳定或改善相关,且可显著增加子宫体积和子宫内膜厚度。中等至高质量证据表明,雌激素联合孕激素或孕激素类药物(包括避孕药)对POI女性有益。

要点

  • 激素治疗在POI女性中优于非治疗、安慰剂、骨化三醇或钙剂,可维持骨密度。
  • 激素治疗与潮热患病率降低最高达80%相关,并伴生活质量评分稳定或改善。
  • 激素治疗可显著增加POI女性的子宫体积和子宫内膜厚度。

核心结论

  • 中等至高质量证据表明,雌激素联合孕激素或孕激素类药物(包括避孕药)的激素治疗对POI女性有益,不仅可缓解低雌激素症状,还可维持骨密度并避免子宫萎缩。
  • 需要更多研究来确认该治疗的长期安全性,并评估其对骨折和心血管事件等硬终点风险的潜在影响。

研究设计与样本

  • 系统综述与荟萃分析,纳入28项研究的30篇报告,共4004例不同病因的POI女性。
  • 3785例接受激素治疗,219例接受钙剂、维生素D、安慰剂或无治疗。

主要发现

  • 激素治疗在维持POI女性骨密度方面优于非治疗、安慰剂、骨化三醇或钙剂。
  • 激素治疗与潮热患病率降低最高达80%相关,并与生活质量评分稳定或改善相关。
  • 激素治疗使POI女性子宫体积和子宫内膜厚度显著增加。
  • 各项研究结果趋同且质量良好,但部分研究缺乏盲法或结局数据不完整。

关键数值与推荐

  • 激素治疗与潮热患病率降低最高达80%相关。
  • 中等至高质量证据支持雌激素联合孕激素或孕激素类药物(包括避孕药)用于POI女性。

临床怎么用

  • 原文未据此给出具体临床推荐。

局限性

  • 部分研究缺乏盲法或结局数据不完整。
  • 需要更多研究来确认该治疗的长期安全性,并评估其对骨折和心血管事件等硬终点风险的潜在影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The aim of this systematic review and meta-analysis was to evaluate the effectiveness of different hormone therapies, including hormonal contraceptives, in women with premature ovarian insufficiency (POI). Thirty reports of 28 studies were included, with a total of 4004 participants with POI from diverse aetiologies, of whom 3785 received hormone therapies and 219 received calcium supplementation, vitamin D, placebo or no treatment. Hormone therapy was superior to non-treatment, placebo, calcitriol or calcium in preserving bone mineral density (BMD) in women with POI. Hormone therapy was associated with up to 80% reduction in the prevalence of hot flushes and with stability or improvement in the quality of life scores. Hormone therapy induced significant increases in uterine volume and endometrial thickness in women with POI. The studies yielded convergent results and were of good quality, although some lacked blinding or had incomplete outcome data. Moderate to high quality evidence was found that hormone therapy with oestrogen and progesterone or progestin (including contraceptives) is beneficial to women with POI, not only to mitigate hypoestrogenic symptoms but also to preserve BMD and avoid uterine atrophy. More studies are needed to confirm the long-term safety of this therapy and to assess its possible impact on the risk of hard outcomes such as bone fractures and cardiovascular events.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Gonçalves CR, Vasconcellos AS, Rodrigues TR, et al. Hormone therapy in women with premature ovarian insufficiency: a systematic review and meta-analysis. Reprod Biomed Online. 2022. PMID: 35461762. doi:10.1016/j.rbmo.2022.02.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。